What does this research mean for the field?

The new Access NT-proBNP assay provides diagnostic and prognostic performance comparable to established reference assays for evaluating suspected acute heart failure in emergency department patients. Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

March 3, 2026Open Access

Evaluation of a New Antibody-Based NT-proBNP Assay for Acute Dyspnea in the Emergency Department

Key Points

The new NT-proBNP assay shows comparable diagnostic performance for acute heart failure to the reference assay.
Prognostic performance highlights its potential effectiveness in emergency department settings for diagnosing acute dyspnea.

Structured PICO

Does the Access NT-proBNP assay provide comparable diagnostic and prognostic performance to a reference assay in ED patients with suspected acute HF?

Population

Emergency Department patients with suspected acute heart failure

Intervention

Access NT-proBNP assay

Comparator

Reference NT-proBNP assay

Outcome

Diagnostic and prognostic performancesurrogate

The new Access NT-proBNP assay is a viable alternative to reference assays for diagnosing and prognosticating acute heart failure in the emergency department.

Abstract

The new Access NT-proBNP assay provides strong diagnostic and prognostic performance in ED patients with suspected acute HF, with results comparable to a reference NT-proBNP assay.

Evaluation of a New Antibody-Based NT-proBNP Assay for Acute Dyspnea in the Emergency Department

Key Points

Structured PICO

Abstract

Cite This Study